2017 Clinical Trials Roundup The Evolution Continues

| November 8, 2018

article image
The landscape of clinical trials continues to evolve over time as scientific breakthroughs and technological innovations emerge, which continue to be tracked by assessing recently initiated trials through Trialtrove’s annual Clinical Trials Roundup.

Spotlight

Acro Pharmaceutical Services

Acro Pharmaceutical Services (Acro) dispenses specialty medications directly to physician offices and to patients’ homes throughout the United States. The prescription drugs that Acro dispenses typically require special handling, clinical and financial support services. The cost of these specialty medications is much higher than those dispensed through retail pharmacies. Acro Pharmaceutical Services offers online pharmacy services such as prescription refills, prior authorization forms, and other services to assist the patient and provider. There are a growing number of specialty drugs available to patients. These specialty medications often focus on, but are not limited to, specific disease states such as Multiple Sclerosis, Psoriasis, Rheumatoid Arthritis, growth hormone deficiency, blood clotting disorders, types of cancer, pulmonary diseases, addiction treatment, mental health disorders, gastrointestinal diseases, rare orphan diseases and many others.

OTHER ARTICLES

Clinical Development Risks and Issues in a COVID-19 World

Article | March 20, 2020

Global clinical guidelines have shifted the industry toward risk-based approaches for the planning and execution of clinical trials. The ICH’s guidelines for Good Clinical Practice state that sponsors should evaluate identified risks against existing risk controls by considering “the likelihood of errors occurring, the extent to which such errors would be detectable, and the impact of such errors on human subject protection and reliability of trial results” (ICH E6 R2).

Read More

How pharma can continue engaging HCPs in a world gripped by COVID-19

Article | March 20, 2020

Medscape is the leading source of clinical news, health information, and point-of-care tools for healthcare professionals. Medscape offers specialists, primary care physicians, and other health professionals the most robust and integrated medical information and educational tools. Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses and other educational programmes for physicians, nurses, and other healthcare professionals. Both Medscape and Medscape Education are part of WebMD Health Corp., an Internet Brands company. Face-to-face interactions between pharma and physicians have essentially ceased overnight during the COVID-19 pandemic, but that doesn’t mean HCPs have stopped looking for new medical information.

Read More

What do you have to lose taking hydroxychloroquine for coronavirus? Potentially your life

Article | March 20, 2020

The president and some of his close advisors — desperate for a COVID-19 cure — are asking “What do you have to lose?” by taking hydroxychloroquine (HCQ), a strong medication never adequately tested for efficacy or safety in COVID-19 patients. The correct answer to the president’s question, which he doesn’t seem to want to hear, is that we have our lives to lose. The president acknowledges “I’m not a doctor” but this raises the question “What do doctors know about the drug recommended by the president? Most doctors are aware that HCQ can be effective for patients with malaria, arthritis or lupus. If they were to follow the president’s suggestion and prescribe it for COVID-19 patients, they would also like to know that it will benefit some of those patients, at least.

Read More
PHARMACY MARKET

A pharma outsourcing mission

Article | March 20, 2020

In a way, getting through the initial stages of a complex pharmaceutical project that is being outsourced to a contract development and manufacturing organization is like getting a rocket off the ground. Many drug developers express frustration with the time it often takes during the initial stages of working with a CDMO — from the time they first reach out to a CDMO for help until they receive a proposal. Some have described it as months of silence from when they send a request for proposal (RFP) until they have a proposal in hand. The initial stages of a relationship between drug sponsor and CDMO often do not get the attention it deserves, and valuable time is lost, delaying projects and delaying delivery of therapeutics to patients. The quick scheduling of the ACT meeting with the right attendees can deliver immediate answers to key questions needed by the drug sponsor for effective planning and can help propel projects to a successful launch.

Read More

Spotlight

Acro Pharmaceutical Services

Acro Pharmaceutical Services (Acro) dispenses specialty medications directly to physician offices and to patients’ homes throughout the United States. The prescription drugs that Acro dispenses typically require special handling, clinical and financial support services. The cost of these specialty medications is much higher than those dispensed through retail pharmacies. Acro Pharmaceutical Services offers online pharmacy services such as prescription refills, prior authorization forms, and other services to assist the patient and provider. There are a growing number of specialty drugs available to patients. These specialty medications often focus on, but are not limited to, specific disease states such as Multiple Sclerosis, Psoriasis, Rheumatoid Arthritis, growth hormone deficiency, blood clotting disorders, types of cancer, pulmonary diseases, addiction treatment, mental health disorders, gastrointestinal diseases, rare orphan diseases and many others.

Events